Torrent Pharma launches nutrition supplement powder Shelcal Total
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
Celecoxib is a nonsteroidal anti-inflammatory drug
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
Subscribe To Our Newsletter & Stay Updated